Ed C. Lavelle researcher
Lavelle, Ed, 19..-....
VIAF ID: 102163628592023460883 (Personal)
Permalink: http://viaf.org/viaf/102163628592023460883
Preferred Forms
- 100 0 _ ‡a Ed C. Lavelle ‡c researcher
- 100 1 _ ‡a Lavelle, Ed, ‡d 19..-....
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degeneration | |
IL-1α and inflammasome-independent IL-1β promote neutrophil infiltration following alum vaccination | |
IL-33 Is a Negative Regulator of Vaccine-Induced Antigen-Specific Cellular Immunity | |
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes | |
Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells. | |
All things mucosal. | |
Autophagy regulates IL-23 secretion and innate T cell responses through effects on IL-1 secretion | |
Biodegradable lamellar particles of poly(lactide) induce sustained immune responses to a single dose of adsorbed protein | |
Caspase-11-Mediated Cell Death Contributes to the Pathogenesis of Imiquimod-Induced Psoriasis | |
Caspase-11 promotes allergic airway inflammation | |
A Common Variant in the Adaptor Mal Regulates Interferon Gamma Signaling. | |
A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. | |
Delivery strategies to enhance oral vaccination against enteric infections. | |
Endogenous Oils Derived From Human Adipocytes Are Potent Adjuvants That Promote IL-1α–Dependent Inflammation | |
Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production. | |
Extracellular cathepsin S and intracellular caspase 1 activation are surrogate biomarkers of particulate-induced lysosomal disruption in macrophages | |
Fas/CD95-induced chemokines can serve as "find-me" signals for apoptotic cells | |
Functionalization of carbon nanoparticles modulates inflammatory cell recruitment and NLRP3 inflammasome activation. | |
Generation of improved mucosal vaccines by induction of innate immunity. | |
Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1α. | |
Harnessing the antibacterial and immunological properties of mucosal-associated invariant T cells in the development of novel oral vaccines against enteric infections. | |
Helminth Products Protect against Autoimmunity via Innate Type 2 Cytokines IL-5 and IL-33, Which Promote Eosinophilia | |
The identification of plant lectins with mucosal adjuvant activity | |
The immune response to a model antigen associated with PLG microparticles prepared using different surfactants | |
Immunological implications of the use of plant lectins for drug and vaccine targeting to the gastrointestinal tract. | |
Immunomodulatory properties of the vaccine adjuvant alum | |
Inhibition of ERK MAPK Suppresses IL-23- and IL-1-Driven IL-17 Production and Attenuates Autoimmune Disease | |
Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. | |
Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer | |
Lectins and microparticles for enhanced oral vaccination. | |
Mechanistic study of the adjuvant effect of chitosan-aluminum nanoparticles | |
Le métabolisme des acides gras à l'interface entre l'hôte et Mycobacterium tuberculosis. | |
Mistletoe lectins enhance immune responses to intranasally co-administered herpes simplex virus glycoprotein D2. | |
Mitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophages | |
Modulation of immune responses using adjuvants to facilitate therapeutic vaccination | |
Molecules of infectious agents as immunomodulatory drugs. | |
Mucosal vaccination against serogroup B meningococci: induction of bactericidal antibodies and cellular immunity following intranasal immunization with NadA of Neisseria meningitidis and mutants of Escherichia coli heat-labile enterotoxin | |
Multivalent presentation of MPL by porous silicon microparticles favors T helper 1 polarization enhancing the anti-tumor efficacy of doxorubicin nanoliposomes | |
Necroptosis suppresses inflammation via termination of TNF- or LPS-induced cytokine and chemokine production | |
Nlrp-3-driven interleukin 17 production by γδT cells controls infection outcomes during Staphylococcus aureus surgical site infection. | |
NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components | |
NLRP3 in protective immunity and vaccination against respiratory infection | |
A novel adjuvanted capsule based strategy for oral vaccination against infectious diarrhoeal pathogens. | |
A novel immunomodulatory hemocyanin from the limpet Fissurella latimarginata promotes potent anti-tumor activity in melanoma | |
An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses | |
Oral immunization of rainbow trout with antigen microencapsulated in poly | |
Osteoarthritis-associated basic calcium phosphate crystals induce pro-inflammatory cytokines and damage-associated molecules via activation of Syk and PI3 kinase | |
PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems | |
Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. | |
Polymyxin B inadequately quenches the effects of contaminating lipopolysaccharide on murine dendritic cells | |
Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: implications for the use of AB toxins as adjuvants in intranasal vaccines. | |
Promotion of trained innate immunity by nanoparticles | |
Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. | |
The role of CD103⁺ dendritic cells in the intestinal mucosal immune system. | |
The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis. | |
The shape and size of hydroxyapatite particles dictate inflammatory responses following implantation | |
Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen | |
The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. | |
Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. | |
The synthesis and biological evaluation of mycobacterial p-hydroxybenzoic acid derivatives (p-HBADs) | |
Targeted nasal vaccination provides antibody-independent protection against Staphylococcus aureus | |
Targeted Strategies for Mucosal Vaccination. | |
Technological Approaches for Improving Vaccination Compliance and Coverage | |
Type I IFN signalling is required for cationic adjuvant formulation (CAF)01-induced cellular immunity and mucosal priming | |
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome | |
The vaccine adjuvant alum promotes IL-10 production that suppresses Th1 responses. | |
The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons |